![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://investors.chromadex.com/news/news-details/2020/New-Preclinical-Study-Finds-Nicotinamide-Riboside-May-Improve-Immune-Cell-Function/default.aspx
https://www.globenewswire.com/news-release/2019/12/11/1959101/0/en/ChromaDex-Launches-Tru-Niagen-Pro-500-the-Largest-Serving-of-Patented-Nicotinamide-Riboside-Available-Worldwide.html
https://www.biospace.com/article/releases/new-study-demonstrates-a-unique-role-of-nicotinamide-riboside-over-other-nad-precursors/?s=95